about
Renal macro- and microcirculation autoregulatory capacity during early sepsis and norepinephrine infusion in rats.The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver diseaseDiagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data.Early administration of vapreotide for variceal bleeding in patients with cirrhosis.Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.Current management of the complications of portal hypertension: variceal bleeding and ascites.The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaLate onset of Wilson's disease in a family with genetic haemochromatosis.Vapreotide acetate for the treatment of esophageal variceal bleeding.IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells.Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in ratsInternal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter.The noninvasive diagnosis of esophageal varices and its application in clinical practice.Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases.Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective study.Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards.Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease.Noninvasive liver steatosis quantification using MRI techniques combined with blood markers.Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding.Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.Spontaneous regression of esophageal varices is a phenomenon that has spontaneously disappeared from our memory.Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis.Sources of variability in histological scoring of chronic viral hepatitis.Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.Prothrombin index is an indirect marker of severe liver fibrosis.Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.Hemodynamic effects of acute and chronic administration of vapreotide in rats with cirrhosis.Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis.Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.Vascular involvement of the liver in Turner's syndrome.Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis.Propranolol in the prevention of ascites.Noninvasive diagnosis of hepatic fibrosis or cirrhosis.
P50
Q22000722-A2496B63-ECF0-433B-B45E-85A137443315Q28730527-D45CF87C-C25B-412C-8E8D-87541A6262CAQ31165156-C6C20924-14CC-4854-A634-2AF883F2AE8FQ31797999-75E33076-D5C4-43F2-B841-E40C8B38C595Q33693646-8D5DF850-6928-47D2-B1F3-12496400BA38Q34523099-32CED366-8E62-428D-A23C-1C5560ABB3A9Q35850620-E9B004F7-4BE5-4647-BA94-99D6E70FF773Q36343361-72FF1537-B071-4C9A-BE85-6307CA1D3BDFQ37345862-CD0AA4F9-9DC2-44C8-A5D6-C48FA911B115Q38971211-421E54D5-F101-41BC-8723-C533AC273C60Q39197576-5123BE4E-68F6-4DE9-A992-9F3E0D93BF61Q39945175-62664833-44D6-4CEB-8F14-1F4952A88E5FQ40058588-26A627E2-B1B8-4355-B678-0472AAB20065Q40319656-87C49557-8A9F-4FAD-98E7-EC61EFC6E20DQ40344131-FA0F98D6-2302-41AB-9FE1-0D39D706CA7AQ40560130-3AA8668E-37D1-42E0-8252-A5CB91C6A8A2Q40680346-59481E76-836B-4D06-8AC6-D6DF2628D4D2Q41325713-A1563CA4-07AE-486D-B823-470797855002Q41441593-838F8C4C-4F09-40A3-BAE6-8DD5893190FEQ41755452-E8069259-2900-4C71-8ED5-C995FC4C8C89Q42215056-4A029F69-E7AC-4DFA-8975-FE2A15CEDD34Q42591497-0F5AA067-8BC2-4168-9C7A-0E2251A583E9Q42953658-B1F7FF0C-C6E4-435D-8664-0C165DBDB6FAQ42954038-9049075A-C1A8-4E24-8A2F-2CEF8470367EQ43242166-44A0C8B7-211D-4265-9C64-DB8F9F8A4CFDQ43466449-FFB0EF22-F962-41D4-AEA6-AA48BA6C8038Q43590280-F8871836-299B-4E2F-AC01-6452C0561C72Q43785759-632CFA85-325C-4F36-94E8-DA0551D7F0C7Q43802819-57E1DEC2-10AD-46B5-A1AA-B8F695A59727Q43816595-FE8A68DD-8EA7-414A-8A25-CA15BB19D492Q44090147-766B887D-350C-4709-9A20-F50F8F416F25Q44166647-F6CC38C9-526F-4DD9-B403-CD352707E507Q44225009-CA8D2F9A-87F0-40FF-97F7-1B17172480B1Q44367945-A7A615C8-1BA8-44DB-8ABE-D139FD229D8BQ44470177-F33474E1-B9C8-4512-AB81-2B316307C6D5Q44590666-AFBD0E9B-030B-4633-A1A3-93E8987BE6BEQ44775848-28CE9E59-2122-4FFA-85F5-874A1B7419D2Q44805217-77842F60-BF60-40F2-941D-44DF42F91785Q45159995-15F45DEA-24BE-4E92-A7EC-21579B125E6FQ45229965-97C66E85-CEB3-482E-AC2C-924D849253EF
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Paul Calès
@ast
Paul Calès
@en
Paul Calès
@es
Paul Calès
@nl
Paul Calès
@sl
type
label
Paul Calès
@ast
Paul Calès
@en
Paul Calès
@es
Paul Calès
@nl
Paul Calès
@sl
prefLabel
Paul Calès
@ast
Paul Calès
@en
Paul Calès
@es
Paul Calès
@nl
Paul Calès
@sl
P214
P106
P1153
7102147457
P21
P213
0000 0003 5898 675X
P214
P31
P496
0000-0003-4866-5274
P735
P7859
viaf-206478858